Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.

Sun Pharma was founded in 1983 by Dilip Shanghvi. The company has a market capitalization of over ₹72,000 crores (US$9.6 billion). Sun Pharma is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.

Sun Pharma has a wide range of products, including tablets, capsules, injectables, liquids, and creams. Its products are used to treat a variety of ailments, including cancer, cardiovascular diseases, diabetes, and respiratory diseases. Sun Pharma also has a research and development division that is constantly working to develop new products.

Sun Pharma is committed to providing high-quality, affordable pharmaceutical products to its customers. The company has a strong quality control system that ensures that its products meet the highest standards. Sun Pharma also has a customer service team that is dedicated to providing its customers with the best possible experience.

Sun Pharma is actively involved in social responsibility initiatives. The company supports a number of programs that promote health and education in India. Sun Pharma also supports disaster relief efforts.

Here are some of the key achievements of Sun Pharma:

• Ranked among the top 10 pharmaceutical companies in the world by market capitalization.
• Winner of the “World Pharma Leader” award by the World Economic Forum in 2018.
• Winner of the “Most Innovative Pharmaceutical Company” award by the Pharmaceutical Executive in 2019.
• Winner of the “Best Pharmaceutical Company” award by the Economic Times in 2020.